CHB Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,164
Closed -$2.61M 81
2025
Q1
$2.61M Buy
3,164
+48
+2% +$39.9K 1.39% 28
2024
Q4
$2.41M Sell
3,116
-4
-0.1% -$3.31K 1.31% 39
2024
Q3
$2.76M Buy
+3,120
New +$2.81M 1.47% 30

Other funds holding LLY

CHB Investment Group's LLY Position: Q2 2025 in Review

CHB Investment Group sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 3,164 shares — an estimated $2.61M sold.

CHB Investment Group first reported a position in LLY in Q3 2024 and held it in 3 quarters. The position peaked at $2.76M in Q3 2024. 3,914 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • CHB Investment Group reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • CHB Investment Group sold 3,164 Eli Lilly shares in Q2 2025, an estimated $2.61M.
  • CHB Investment Group first reported a position in Eli Lilly in Q3 2024 and held it in 3 quarters.
  • CHB Investment Group's Eli Lilly position peaked at $2.76M in Q3 2024.
  • 3,914 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on CHB Investment Group's 13F filing for Q2 2025, filed 15 Jul 2025.